Enfusion, Inc. Annual Income Tax Expense (Benefit) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Enfusion, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
  • Enfusion, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $904K, a 146% increase year-over-year.
  • Enfusion, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $2.47M, a 80.3% increase year-over-year.
  • Enfusion, Inc. annual Income Tax Expense (Benefit) for 2023 was $2.23M, a 108% increase from 2022.
  • Enfusion, Inc. annual Income Tax Expense (Benefit) for 2022 was $1.07M, a 85.5% increase from 2021.
  • Enfusion, Inc. annual Income Tax Expense (Benefit) for 2021 was $579K, a 33.7% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.23M +$1.16M +108% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 $1.07M +$495K +85.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 $579K +$146K +33.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-12
2020 $433K -$53K -10.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-10
2019 $486K Jan 1, 2019 Dec 31, 2019 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.